Humedix휴메딕스
200670 · KOSDAQ · ₩200670 · 휴메딕스
₩23,700▲ ₩750 (3.27%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 45.0% | 46.8% | 46.3% | 46.2% | 44.4% | 37.2% |
| Operating margin | 22.9% | 24.9% | 26.7% | 24.5% | 21.1% | 13.0% |
| Net margin | 25.8% | 30.5% | 24.3% | 16.3% | 17.2% | 9.6% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +4.6% | +5.1% | +6.3% | +23.6% | +31.5% | — |
| Operating income growth | −3.9% | −1.9% | +15.6% | +43.3% | +113.5% | — |
| Net income growth | −11.3% | +31.9% | +58.2% | +17.3% | +135.3% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 15.1% | 19.6% | 18.4% | 14.7% | 16.1% | 7.3% |
| Return on assets | 13.9% | 18.1% | 16.7% | 11.1% | 10.0% | 4.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 8.6% | 8.0% | 9.3% | 11.1% | 63.3% | 58.2% |
| Net debt to equity | — | — | −48.3% | −40.5% | −42.0% | 16.3% |
| Current ratio | 729.8% | 869.9% | 826.9% | 665.0% | 165.8% | 263.8% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Humedix / 휴메딕스 / 200670 / KRX:200670
Source: KRX statistical information